nouryant
kyowa kirin holdings b.v. - istradefylline - Паркинсонова болест - Антипаркинсонови лекарства - istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with parkinson’s disease (pd) experiencing “off” time.
wilate 500 500 iu von willebrand factor and 500 iu factor viii powder and solvent for solution for injection
octapharma (ip) limited - фактор Виллебранда и коагуляционного фактор viii в комбинация - 500 iu von willebrand factor and 500 iu factor viii powder and solvent for solution for injection
wilate 1000 1000 iu von willebrand factor and 1000 iu factor viii powder and solvent for solution for injection
octapharma (ip) limited - фактор Виллебранда и коагуляционного фактор viii в комбинация - 1000 iu von willebrand factor and 1000 iu factor viii powder and solvent for solution for injection
ketilept retard 150 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 150 mg prolonged - release tablets
ketilept retard 50 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 50 mg prolonged - release tablets
ketilept retard 200 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 200 mg prolonged - release tablets
ketilept retard 300 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 300 mg prolonged - release tablets
ketilept retard 400 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 400 mg prolonged - release tablets